Berberine attenuates obesity‐induced insulin resistance by inhibiting miR ‐27a secretion
Diabetic Medicine · 2024
DOI: 10.1111/dme.15319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, 2024. Verfasst von Junda Du und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Basic Medical Sciences, School of nursing, Jilin University, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Berberine, Insulin Resistance, Obesity, MicroRNAs. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Development Projects of Jilin Province, Interdisciplinary Integration and Innovation Project of JLU.
Abstract (Originalsprache)
Introduction
Berberine (BBR) is an alkaloid found in plants. It has neuroprotective, anti‐inflammatory and lipid‐lowering activity. However, the efficacy of treatment with BBR and the mechanisms through which it acts need further study.
Aims
This study investigated the therapeutic effects and the mechanism of action of BBR on obesity‐induced insulin resistance in peripheral tissues.
Methods
High‐fat‐fed C57BL/6J mice and low‐fat‐fed C57BL/6J mice with miR‐27a overexpression were given BBR intervention (100 mg/kg, po), and the oral glucose tolerance test (OGTT) and insulin tolerance test (ITT) were performed. Palmitic acid‐stimulated hypertrophic adipocyte models were treated with BBR (10 μM). Related indicators and protein expression levels were examined.
Results
The AUCs of the OGTT and the ITT in the BBR intervention group were reduced significantly ( p < 0.01) ( p < 0.05), and the serum biochemical parameters, including FBG, TC, TG and LDL‐C were significantly reduced after BBR intervention. In the in vitro experiments, the triglyceride level and volume of lipid droplets decreased significantly after BBR intervention ( p < 0.01) ( p < 0.05). Likewise, BBR ameliorates skeletal muscle and pancreas insulin signalling pathways in vivo and in vitro.
Discussion
The results showed that BBR significantly ameliorated insulin resistance, reduced body weight and percent body fat and improved serum biochemical parameters in mice. Likewise, BBR reduced triglyceride level and lipid droplet volume in hypertrophic adipocytes, BBR improved obesity effectively. Meanwhile, BBR ameliorated the histomorphology of the pancreas, and skeletal muscle and pancreas insulin related signalling pathways of islets in in vitro and in vivo experiments. The results further demonstrated that BBR inhibited miR‐27a levels in serum from obese mice and supernatant of hypertrophic adipocytes. miR‐27a overexpression in low‐fat fed mice indicated that miR‐27a caused insulin resistance, and BBR intervention significantly improved the miR‐27a induced insulin resistance status.
Conclusion
This study demonstrates the important role of BBR in obesity‐induced peripheral insulin resistance and suggest that the mechanism of its effect may be inhibition of miR‐27a secretion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, College of Basic Medical Sciences, School of nursing, Jilin University, Changchun, Jilin, China.
- School of Pharmaceutical Science, Jilin University, Changchun, Jilin, China.
- Department of Ophthalmology of Jilin Province FAW General Hospital, Changchun, Jilin, China.
ORCID-Profile: Meishuang Zhang, Ming Zhang
Förderung
- National Natural Science Foundation of China
- Science and Technology Development Projects of Jilin Province
- Interdisciplinary Integration and Innovation Project of JLU
- Science and Technology Development Projects of Changchun
- Scientific Research Project of Jilin Provincial Department of Education
- Norman Bethune Program of Jilin University
Zitieren
APA
Du, J., Zhu, Y., Yang, X., Geng, X., Xu, Y., Zhang, M., & Zhang, M. (2024). Berberine attenuates obesity‐induced insulin resistance by inhibiting miR ‐27a secretion. Diabetic Medicine. https://doi.org/10.1111/dme.15319
Vancouver
Du J, Zhu Y, Yang X, Geng X, Xu Y, Zhang M, et al. Berberine attenuates obesity‐induced insulin resistance by inhibiting miR ‐27a secretion. Diabetic Medicine. 2024. doi:10.1111/dme.15319
BibTeX
@article{Du2024,
author = {Du, Junda and Zhu, Yu and Yang, Xuehan and Geng, Xinru and Xu, Yang and Zhang, Meishuang and Zhang, Ming},
title = {Berberine attenuates obesity‐induced insulin resistance by inhibiting miR ‐27a secretion},
journal = {Diabetic Medicine},
year = {2024},
doi = {10.1111/dme.15319}
}
EUVIMED